Comparison Between Cyclophosphamide and Combination of Methotrexate + Calcineurin Inhibitor for GVHD Prophylaxis

Clinical trial NCT01749111 · TERMINATED

Trial details

NCT number: NCT01749111
Sponsor: Hospital Israelita Albert Einstein
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Myelogenous Leukemia Acute Lymphoid Leukemia Myeloproliferative Disease Myelodysplastic Syndrome Chronic Myeloid Leukemia Chronic Myelomonocytic Leukemia

Start date: 2012-12-01
Primary completion: 2016-08-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.